Bionet (1784) - Total Liabilities

Latest as of September 2025: NT$855.33 Million TWD ≈ $26.95 Million USD

Based on the latest financial reports, Bionet (1784) has total liabilities worth NT$855.33 Million TWD (≈ $26.95 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 1784 operating cash flow to assess how effectively this company generates cash.

Bionet - Total Liabilities Trend (2017–2024)

This chart illustrates how Bionet's total liabilities have evolved over time, based on quarterly financial data. Check Bionet liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Bionet Competitors by Total Liabilities

The table below lists competitors of Bionet ranked by their total liabilities.

Company	Country	Total Liabilities
Menang Corporation (Malaysia) Bhd KLSE:1694	Malaysia	RM309.17 Million
ELK-Desa Resources Bhd KLSE:5228	Malaysia	RM412.26 Million
Creepy Jar SA WAR:CRJ	Poland	zł5.49 Million
TuHURA Biosciences Inc NASDAQ:HURA	USA	$6.42 Million
Siam Pan Group PCL BK:SPG	Thailand	฿457.05 Million
Abra Information Technologies TA:ABRA	Israel	ILA283.61 Million
Bcl Industries Limited NSE:BCLIND	India	Rs7.94 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Bionet's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bionet market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.20	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.68	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bionet's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bionet (2017–2024)

The table below shows the annual total liabilities of Bionet from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$760.40 Million ≈ $23.96 Million	+21.38%
2023-12-31	NT$626.47 Million ≈ $19.74 Million	+21.89%
2022-12-31	NT$513.97 Million ≈ $16.19 Million	+9.78%
2021-12-31	NT$468.19 Million ≈ $14.75 Million	+5.11%
2020-12-31	NT$445.44 Million ≈ $14.03 Million	-1.86%
2019-12-31	NT$453.87 Million ≈ $14.30 Million	+2.43%
2018-12-31	NT$443.09 Million ≈ $13.96 Million	-2.26%
2017-12-31	NT$453.33 Million ≈ $14.28 Million	--

About Bionet

TWO:1784 Taiwan Diagnostics & Research

Market Cap

$115.06 Million

NT$3.65 Billion TWD

Market Cap Rank

#18678 Global

#1027 in Taiwan

Share Price

NT$72.60

Change (1 day)

+0.97%

52-Week Range

NT$64.60 - NT$115.50

All Time High

NT$161.50